U.S. Markets closed

Ascentage Pharma Group International (ASPHF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
6.100.00 (0.00%)
At close: 9:36AM EDT
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Yahoo Finance Plus required to access monthly data
Subscribe to Yahoo Finance Plus Essential to download historical data
We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 36.10
52 Week Low 36.10
50-Day Moving Average 36.10
200-Day Moving Average 36.10

Share Statistics

Avg Vol (3 month) 3N/A
Avg Vol (10 day) 3N/A
Shares Outstanding 5252.73M
Implied Shares Outstanding 6N/A
Float 146.79M
% Held by Insiders 136.81%
% Held by Institutions 111.45%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in CNY.

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Dec 30, 2020


Profit Margin 0.00%
Operating Margin (ttm)-5,497.42%

Management Effectiveness

Return on Assets (ttm)-29.14%
Return on Equity (ttm)-78.02%

Income Statement

Revenue (ttm)12.45M
Revenue Per Share (ttm)0.06
Quarterly Revenue Growth (yoy)-19.30%
Gross Profit (ttm)10.48M
EBITDA -667.46M
Net Income Avi to Common (ttm)-677.61M
Diluted EPS (ttm)N/A
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.03B
Total Cash Per Share (mrq)4.65
Total Debt (mrq)529.7M
Total Debt/Equity (mrq)62.57
Current Ratio (mrq)3.91
Book Value Per Share (mrq)N/A

Cash Flow Statement

Operating Cash Flow (ttm)-609.96M
Levered Free Cash Flow (ttm)-493.55M